The Compounding Adverse Drug Events Reporting (C-ADER) program will provide a standardized tool for compounding pharmacies to simply and effectively track and report any adverse events that are potentially associated with compounded medications.

Pharmacies that license the program and report patient safety events to APMS are now provided federal legal protection to information that is reported, investigation, analysis and follow-up to any event that is potential associated with the use of a compounded medication.  APMS staff will work with pharmacy staff to provide program support with safe practice and workflow process recommendations. Pharmacies reporting through APMS will also receive recommendations on best practices and workflow processes to help reduce medication errors, improve medication use and enhance patient safety and health outcomes.

Pharmacies enter into a license agreement and a business associate’s agreement with APMS. Initial cost of the program is $150 and can be renewed annually.